Quantitative measurement of HER2 levels by multiplexed mass spectrometry to predict survival in gastric cancer patients treated with trastuzumab.

被引：0
|
作者：
Ock, Chan-Young
An, Eunkyung
Oh, Do-Youn
Kim, Tae-Yong
Lee, Kyung-Hun
Han, Sae-Won
Im, Seock-Ah
Kim, Tae-You
Liao, Wei-Li
Cecchi, Fabiola
Blackler, Adele
Thyparambil, Sheeno P.
Hoos, William Arthur
Kim, Woo Ho
Burrows, Jon
Hembrough, Todd A.
Bang, Yung-Jue
机构：
[1] Seoul Natl Univ Hosp, Seoul 110744, South Korea
[2] OncoPlex Diagnost, Rockville, MD USA
[3] Seoul Natl Univ Hosp, Dept Internal Med, Seoul 110744, South Korea
[4] Seoul Natl Univ, Coll Med, Dept Internal Med, Seoul Natl Univ Hosp,Canc Res Inst, Seoul 151, South Korea
[5] Seoul Natl Univ, Coll Med, Seoul, South Korea
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2015年 / 33卷 / 15期
关键词：
D O I：
10.1200/jco.2015.33.15_suppl.4050
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
4050
引用
收藏
页数：1
相关论文
共 50 条
  • [1] Quantitative measurement of HER2 levels by multiplexed mass spectrometry from FFPE tissue predicts survival in patients treated with anti-HER2 based therapy
    Nuciforo, Paolo
    Thyparambil, Sheeno
    Aura, Claudia
    Garrido-Castro, Ana
    Peg, Vicente
    Jimenez, Jose
    Hoos, William
    Burrows, Jon
    Hembrough, Todd
    Perez-Garcia, Jose
    Cortes, Javier
    Scaltriti, Maurizio
    CANCER RESEARCH, 2015, 75
  • [2] Survival of patients with HER2-positive gastric cancer with introduction of trastuzumab.
    Shitara, Kohei
    Yatabe, Yasushi
    Sugano, Masato
    Matsuo, Keitaro
    Kondo, Chihiro
    Takahari, Daisuke
    Ura, Takashi
    Tajika, Masahiro
    Muro, Kei
    JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (04)
  • [3] PI3K upregulation as a negative predictive factor of survival in HER2 amplified gastric cancer treated with Trastuzumab.
    Diaz-Serrano, Asuncion
    Lopez-Rios, Fernando
    Dominguez, Carolina
    Fonseca, Paula J.
    Angulo, Barbara
    Cid, Roberto A. Pazo
    Plaza, Carlos
    Rivera, Fernando
    Rodriguez, Margarita
    Leon, Ana
    Prieto, Susana Hernandez
    Paz-Ares, Luis
    Gomez-Martin, Carlos
    JOURNAL OF CLINICAL ONCOLOGY, 2016, 34 (15)
  • [4] Quantitative HER2 Protein Levels Predict Outcome In Fluorescence In Situ Hybridization-Positive Patients With Metastatic Breast Cancer Treated With Trastuzumab
    Lipton, Allan
    Koestler, Wolfgang J.
    Leitzel, Kim
    Ali, Suhail M.
    Sperinde, Jeff
    Weidler, Jodi
    Paquet, Agnes
    Sherwood, Thomas
    Huang, Weidong
    Bates, Michael
    CANCER, 2010, 116 (22) : 5168 - 5178
  • [5] HER2 STATUS IN ADVANCED GASTRIC CARCINOMA PATIENTS TREATED WITH TRASTUZUMAB
    Gomez-Martin, C.
    Plaza, J. C.
    Del Valle, E.
    Pons Valladares, F.
    Jimenez Fonseca, P.
    Salud, A.
    Leon, A.
    Rivera, F.
    Garralda, E.
    Lopez-Rios, F.
    ANNALS OF ONCOLOGY, 2012, 23 : 233 - 234
  • [6] Quantitative proteomic analysis of HER2 expression in the selection of gastric cancer patients for trastuzumab treatment
    An, E.
    Ock, C-Y
    Kim, T-Y
    Lee, K-H
    Han, S-W
    Im, S-A
    Kim, T-Y
    Liao, W-L
    Cecchi, F.
    Blackler, A.
    Thyparambil, S.
    Kim, W. H.
    Burrows, J.
    Hembrough, T.
    Catenacci, D. V. T.
    Oh, D-Y
    Bang, Y-J
    ANNALS OF ONCOLOGY, 2017, 28 (01) : 110 - 115
  • [7] Survival of patients with metastatic HER2 positive gastroesophageal cancer treated with second-line chemotherapy plus trastuzumab or ramucirumab after progression on frontline chemotherapy plus trastuzumab.
    Moser, Justin
    Solomon, Benjamin
    Nevala-Plagemann, Christopher Duane
    Gilcrease, Glynn Weldon
    Whisenant, Jonathan R.
    Garrido-Laguna, Ignacio
    JOURNAL OF CLINICAL ONCOLOGY, 2019, 37 (04)
  • [8] Use of total HER2 and HER2 homodimer levels to predict response to trastuzumab
    Leitzel, K.
    Lipton, A.
    Koestler, W.
    Fuchs, E.
    Ali, S. M.
    Weidler, J.
    Wu, Y.
    Sperinde, J.
    Huang, W.
    Bates, M.
    JOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (15)
  • [9] pCR as a Surrogate in HER2-Positive Patients Treated with Trastuzumab.
    Loibll, S.
    von Minckwitz, G.
    Blohmer, J. U.
    Costa, S. D.
    Eidtmann, H.
    Fasching, P. A.
    Gerber, B.
    Hanusch, C.
    Hilfrich, J.
    Huober, J.
    Jackisch, C.
    Kaufmann, M.
    Konecny, G.
    Denkert, C.
    Nekljudova, V.
    Mehta, K.
    Untch, M.
    CANCER RESEARCH, 2011, 71
  • [10] Cardiotoxicity of trastuzumab in the patients with HER2 positive advanced gastric cancer
    Jung, M.
    Park, J. S.
    Lee, C-K.
    Kim, J. H.
    Park, H. S.
    Heo, S. J.
    Beom, S. H.
    Kim, H. S.
    Rha, S. Y.
    Chung, H. C.
    Youn, J-C.
    ANNALS OF ONCOLOGY, 2016, 27
12345